Cargando…

Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study)

Previous studies have found suboptimal control of symptom burden to be widespread among patients with asthma and chronic obstructive pulmonary disease (COPD). The Phase IV SPRINT study was conducted in 10 countries in Europe to assess asthma disease control and COPD symptom burden in patients treate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roche, Nicolas, Plaza, Vicente, Backer, Vibeke, van der Palen, Job, Cerveri, Isa, Gonzalez, Chelo, Safioti, Guilherme, Scheepstra, Irma, Patino, Oliver, Singh, Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946676/ https://www.ncbi.nlm.nih.gov/pubmed/31911607 http://dx.doi.org/10.1038/s41533-019-0159-1

Ejemplares similares

Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD
por: Giner, Jordi, et al.
Publicado: (2020)

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2018)

Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD
por: Kocks, Janwillem W. H., et al.
Publicado: (2018)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016)

Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients
por: Plaza, Vicente, et al.
Publicado: (2016)

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices
por: van der Palen, Job, et al.
Publicado: (2016)

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices
por: van der Palen, Job, et al.
Publicado: (2017)

Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2018)

Investigating the Accuracy of the Digihaler, a New Electronic Multidose Dry-Powder Inhaler, in Measuring Inhalation Parameters
por: Chrystyn, Henry, et al.
Publicado: (2022)

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
por: D’Urzo, Anthony, et al.
Publicado: (2019)

Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers
por: Rönmark, Per, et al.
Publicado: (2018)

Advancing Digital Solutions to Overcome Longstanding Barriers in Asthma and COPD Management
por: Bosnic-Anticevich, Sinthia, et al.
Publicado: (2023)

Early detection of COPD in primary care -The Copenhagen COPD Screening Project
por: Lyngsø, Anne Marie, et al.
Publicado: (2010)

Clinical Impact of Electronic Monitoring Devices of Inhalers in Adults with Asthma or COPD: A Systematic Review and Meta-Analysis
por: Garin, Noe, et al.
Publicado: (2023)

Device errors in asthma and COPD: systematic literature review and meta-analysis
por: Chrystyn, Henry, et al.
Publicado: (2017)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
por: Price, David B, et al.
Publicado: (2022)

A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD
por: van der Palen, Job, et al.
Publicado: (2018)

Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD
por: Prakash, Anoop, et al.
Publicado: (2015)

Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease
por: Løkke, Anders, et al.
Publicado: (2015)

Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
por: Hajian, Bita, et al.
Publicado: (2016)

The use of COPD maintenance therapy following spirometry in General Practice
por: Gottlieb, Vibeke, et al.
Publicado: (2016)

“All I want for Christmas is Two”: The Advent of Novel Fixed-Combination Inhalers for COPD and Outlook for 2014
por: Beeh, Kai M.
Publicado: (2013)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids
por: van den Berge, Maarten, et al.
Publicado: (2021)

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study
por: Citgez, Emanuel, et al.
Publicado: (2016)

A review of the value of innovation in inhalers for COPD and asthma
por: Virchow, Johann Christian, et al.
Publicado: (2015)

Choosing the right inhaler for your asthma or COPD patient
por: Usmani, Omar S
Publicado: (2019)

Carbon footprint impact of the choice of inhalers for asthma and COPD
por: Janson, Christer, et al.
Publicado: (2020)

Control in asthma and COPD – correct inhaler technique is crucial
por: Irusen, E M
Publicado: (2019)

Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review
por: Klijn, Sven L., et al.
Publicado: (2017)

Upper airway symptoms associate with the eosinophilic phenotype of COPD
por: Obling, Nicolai, et al.
Publicado: (2021)

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study
por: Price, David B., et al.
Publicado: (2018)

Severe outcomes of COVID-19 among patients with COPD and asthma
por: Hansen, Erik Soeren Halvard, et al.
Publicado: (2021)

Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
por: Pace, Elisabetta, et al.
Publicado: (2022)

Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men
por: Dyreborg, Anders, et al.
Publicado: (2016)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
por: Martin, Clémence, et al.
Publicado: (2021)

Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD
por: Chetta, Alfredo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6ibt7b3eb2mn2f5semb7mgut0c